# A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants

> **NCT06991179** · PHASE1 · COMPLETED · sponsor: **Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY4064809

## Key facts

- **NCT ID:** NCT06991179
- **Lead sponsor:** Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-20
- **Primary completion:** 2025-09-02
- **Final completion:** 2025-09-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06991179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06991179, "A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06991179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*